全球区域麻疹消除进展——2000-2021年
本报告描述2000-2021年全球麻疹消除进展。全球MCV1覆盖率从2000年72%升至2019年86%峰值,COVID-19疫情期间降至2020年83%和2021年81%。
要点
- 2021年全球MCV1覆盖率81%,为2008年以来最低。
- 2000-2021年估计麻疹死亡数下降83%,从761,000降至128,000。
- 2021年仅47/135(35%)报告废弃病例的国家达到敏感性指标。
核心结论
- 为在COVID-19疫情期间及之后重获进展并实现区域麻疹消除目标,需加速针对性努力使所有儿童获得2剂MCV,同时实施强有力监测并发现和填补免疫空白以预防病例和暴发。
研究设计与样本
- 本报告描述2000-2021年全球麻疹消除进展,并更新此前报告。
主要发现
- 2000-2021年全球估计MCV1覆盖率从72%升至2019年86%峰值,COVID-19疫情期间降至2020年83%和2021年81%,为2008年以来最低MCV1覆盖率。
- 所有国家均开展麻疹监测,但2021年135个报告废弃病例的国家中仅47个(35%)达到每10万人口≥2例废弃病例的敏感性指标目标。
- 2000-2016年年报告麻疹发病率下降88%,从每100万人口145例降至18例,2019年全球复燃期间回升至120例,2020年降至21例,2021年降至17例。
- 22个国家报告了大规模且具破坏性的暴发。
关键数值与推荐
- IA2030强调确保严格麻疹监测系统以记录免疫空白,并在儿童中实现2剂及时MCV接种覆盖率95%。
- 2021年敏感性指标目标为每10万人口≥2例废弃病例。
临床怎么用
- 需加速针对性努力使所有儿童获得2剂MCV,同时实施强有力监测并发现和填补免疫空白以预防病例和暴发。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
All six World Health Organization (WHO) regions have committed to eliminating measles.* The Immunization Agenda 2021-2030 (IA2030)† aims to achieve the regional targets as a core indicator of impact and positions measles as the tracer of a health system's ability to deliver essential childhood vaccines. IA2030 highlights the importance of ensuring rigorous measles surveillance systems to document immunity gaps and achieve 95% coverage with 2 timely doses of measles-containing vaccine (MCV) among children. This report describes progress toward measles elimination during 2000-2021 and updates a previous report (1). During 2000-2021, estimated global coverage with a first MCV dose (MCV1) increased from 72% to a peak of 86% in 2019, but decreased during the COVID-19 pandemic to 83% in 2020 and to 81% in 2021, the lowest MCV1 coverage recorded since 2008. All countries conducted measles surveillance, but only 47 (35%) of 135 countries reporting discarded cases§ achieved the sensitivity indicator target of two or more discarded cases per 100,000 population in 2021, indicating surveillance system underperformance in certain countries. Annual reported measles incidence decreased 88% during 2000-2016, from 145 to 18 cases per 1 million population, then rebounded to 120 in 2019 during a global resurgence (2), before declining to 21 in 2020 and to 17 in 2021. Large and disruptive outbreaks were reported in 22 countries. During 2000-2021, the annual number of estimated measles deaths decreased 83%, from 761,000 to 128,000; an estimated 56 million measles deaths were averted by vaccination. To regain progress and achieve regional measles elimination targets during and after the COVID-19 pandemic, accelerating targeted efforts is necessary to reach all children with 2 MCV doses while implementing robust surveillance and identifying and closing immunity gaps to prevent cases and outbreaks.
引用
- Minta AA, Ferrari M, Antoni S, et al. Progress Toward Regional Measles Elimination - Worldwide, 2000-2021. MMWR Morb Mortal Wkly Rep. 2022. PMID: 36417303. doi:10.15585/mmwr.mm7147a1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。